GSK and Theravance announce regulatory submission for ANORO™ ELLIPTA™ in Japan
22 April 2013 | By GlaxoSmithKline
Submission of a regulatory application to the Japanese MHLW...
List view / Grid view
22 April 2013 | By GlaxoSmithKline
Submission of a regulatory application to the Japanese MHLW...
22 April 2013 | By AstraZeneca
“We are excited to grow this collaboration..."
22 April 2013 | By Merck
Agreement to conduct a Phase II clinical trial evaluating combination of investigational oral candidates MK-5172 and daclatasvir for chronic hepatitis C...
19 April 2013 | By Novartis
A new beta blocker-free, fixed-combination therapy for glaucoma patients...
19 April 2013 | By Baxter International Inc.
Baxter has reported first quarter financial results in line with the company's previously issued guidance...
19 April 2013 | By Johnson & Johnson
Janssen will receive $11.25 per ADS which will result in an after-tax gain of approximately $213m...
18 April 2013 | By Abbott
TECNIS® Toric 1-Piece intraocular lens has received U.S. FDA approval...
17 April 2013 | By Zyme Communications
Argenta has signed a collaboration agreement with Boehringer Ingelheim...
17 April 2013 | By B&W Tek, Inc.
B&W Tek, Inc., is proud to announce major enhancements to their NanoRam handheld Raman spectrometer...
17 April 2013 | By Sanofi
Sanofi announced the opening of its new logistics hub in Casablanca, Morocco...
16 April 2013 | By kdm communications limited
Tecan has launched a new online training tool that makes it easier than ever before for customers to optimize their instrument use...
Abbott today announced the global launch of the ACCELERATOR® a3600, a next generation automation solution, to help laboratories address the need to process tests faster while handling increased volume. Advances in technology and automation within the lab have led to more timely results leading to improved patient care. Automation systems…
16 April 2013 | By Merck
New facility to deliver innovative, high-quality Merck medicines to Asia...
Thermo Fisher Scientific (NYSE: TMO), the world leader in serving science, and Life Technologies Corporation (NASDAQ: LIFE), a leading life sciences company, have signed a definitive agreement under which Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share, or approximately $13.6 billion, plus the…
15 April 2013 | By Roche
Roche and Ascletis have entered into a collaboration...